Eupraxia Pharmaceuticals Inc (EPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 16,163 | 6,883 | 8,264 | 7,124 | 7,482 |
| Operating Income | -16,163 | -6,883 | -8,264 | -7,124 | -7,482 |
| Other Income | -547 | 513 | -478 | 360 | -49 |
| Pre-tax Income | -16,710 | -6,370 | -8,742 | -6,765 | -7,531 |
| Income Tax | 23 | -1 | -6 | 3 | -8 |
| Net Income Continuous | -16,733 | -6,369 | -8,737 | -6,767 | -7,522 |
| Minority Interests | -10 | -8 | -7 | -5 | -23 |
| Net Income | $-16,711 | $-6,361 | $-8,741 | $-6,763 | $-7,509 |
| EPS Basic Total Ops | -0.37 | -0.19 | -0.26 | -0.21 | -0.21 |
| EPS Basic Continuous Ops | -0.36 | -0.17 | -0.24 | -0.19 | -0.21 |
| EPS Diluted Total Ops | -0.37 | -0.19 | -0.26 | -0.21 | -0.21 |
| EPS Diluted Continuous Ops | -0.36 | -0.17 | -0.24 | -0.19 | -0.21 |
| EPS Diluted Before Non-Recurring Items | -0.37 | -0.19 | -0.26 | -0.21 | -0.21 |
| EBITDA(a) | $-16,090 | $-6,820 | $-8,209 | $-7,078 | $-7,427 |